B-type natriuretic peptide in patients undergoing orthopaedic surgery: a prospective cohort study

被引:17
|
作者
Breidthardt, Tobias [1 ]
Kindler, Christoph H. [2 ]
Schindler, Christian [3 ]
Futterer, Moreno [1 ]
Yonekawa, Keiko [1 ]
Mueller, Christian [1 ]
机构
[1] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland
[2] Kantonsspital Aarau, Dept Anesthesia, Aarau, Switzerland
[3] Univ Basel Hosp, Inst Social & Prevent Med, CH-4031 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
B-type natriuretic peptide; orthopaedic surgery; outcome; postoperative complications; N-TERMINAL FRAGMENT; NONCARDIAC SURGERY; HEART-FAILURE; CARDIOVASCULAR EVALUATION; CARDIAC EVENTS; DIAGNOSIS; RISK; MORTALITY; UTILITY; PREDICTOR;
D O I
10.1097/EJA.0b013e328336c654
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background and objective Postoperative cardiac complications pose a substantial risk to patients undergoing orthopaedic surgery. Methods B-type natriuretic peptide (BNP) was determined preoperatively in 270 patients undergoing scheduled orthopaedic surgery. The accuracy of BNP to predict the occurrence of in-hospital cardiac events was evaluated as the primary endpoint. Cardiac events at 1 year of follow-up were considered secondary endpoints. Results Preoperative BNP levels were significantly higher in the four patients experiencing in-hospital cardiac events than in patients without events [median 306 pg ml(-1) (range 123-3958) vs. 35 pg ml(-1) (range 14-2074), P = 0.01]. In a receiver operating characteristic analysis for the prediction of in-hospital cardiac events, the area under the receiver operating characteristic curve for BNP was 0.86 (95% confidence interval 0.74-0.99). The optimal predictive accuracy was achieved with a BNP threshold of 174 pg ml(-1). Importantly, the combination of BNP and the American Society of Anesthesiologists score further improved this accuracy. Additionally, BNP retained a high predictive accuracy in the subgroup of patients with known cardiac diseases [area under the receiver operating characteristic curve 0.85 (95% confidence interval from 0.65 to <1)]. The area under the receiver operating characteristic curve for the prediction of long-term cardiac events by BNP was 0.71 (95% confidence interval 0.57-0.84). Conclusion In patients undergoing orthopaedic surgery, preoperative BNP levels can predict short-term and long-term postoperative cardiac events. Despite the paucity of endpoint events observed in this study, our results are in agreement with all prior investigations. BNP used in addition to an American College of Cardiology/American Heart Association guideline-based risk assessment might, therefore, be a useful tool in the preoperative evaluation of patients undergoing orthopaedic surgery. Eur J Anaesthesiol 2010; 27:690-695
引用
收藏
页码:690 / 695
页数:6
相关论文
共 50 条
  • [1] PROGNOSTIC VALUE OF A B-TYPE NATRIURETIC PEPTIDE IN PATIENTS WITH PNEUMONIA: A PROSPECTIVE COHORT STUDY
    Takeshima, Kento
    Usuda, Daisuke
    Sangen, Ryusho
    Kasamaki, Yuji
    RESPIROLOGY, 2017, 22 : 35 - 36
  • [2] Preoperative B-type natriuretic peptide testing in patients undergoing noncardiac surgery
    Rumman, Rawan
    Venus, Kevin
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (39) : E1350 - E1350
  • [3] B-Type Natriuretic Peptide (BNP) in Patients Undergoing Mitral Valve Surgery
    Filsoufi, Farzan
    Rahmanian, Parwis B.
    Salzberg, Sacha
    von Harbou, Kai
    Bodian, Carol A.
    Adams, David H.
    JOURNAL OF CARDIAC SURGERY, 2008, 23 (06) : 600 - 605
  • [4] Validation of a B-type natriuretic peptide as a prognostic marker in pneumonia patients: a prospective cohort study
    Usuda, Daisuke
    Sangen, Ryusho
    Hashimoto, Yu
    Muranaka, Emiri
    Iinuma, Yoshitsugu
    Kanda, Tsugiyasu
    BMJ OPEN, 2016, 6 (02):
  • [5] SERIAL MEASUREMENTS OF B-TYPE NATRIURETIC PEPTIDE (BNP) IN PATIENTS UNDERGOING CARDIAC SURGERY
    Turner, H.
    Reeve, J.
    McNeilly, J.
    Mutch, W.
    Peake, R.
    Rae, D.
    Gibson, P.
    Hillis, G.
    Cuthbertson, B.
    Croal, B.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A159 - A159
  • [6] B-type natriuretic peptide as a surrogate marker for survival in patients undergoing cardiac surgery
    Lim, Ju Yong
    Jung, Sung Ho
    Choo, Suk Jung
    Chung, Cheol Hyun
    Lee, Jae Won
    Kim, Joon Bum
    JOURNAL OF THORACIC DISEASE, 2021, 13 (02) : 955 - 967
  • [7] The prognostic utility of B-type natriuretic peptide (BNP) in patients undergoing cardiac surgery
    Cuthbertson, B. G.
    McNeilly, J. D.
    Mutch, W. J.
    Hilis, G. S.
    Rae, D.
    Gibson, P.
    Jeffrey, R.
    Buchan, K.
    El-Shafei, H.
    Gibson, G.
    Croal, B. L.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A82 - A82
  • [8] PROGNOSTIC VALUE OF B-TYPE NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC MITRAL REGURGITATION UNDERGOING SURGERY
    Hwang, In-Chang
    Kim, Yong-Jin
    Kim, Kyung-Hee
    Lee, Seung-Pyo
    Kim, Hyung-Kwan
    Sohn, Dae Won
    Oh, Byung-Hee
    Park, Young-Bae
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1976 - E1976
  • [9] The prognostic value of preoperative B-type natriuretic peptide in patients undergoing coronary bypass surgery
    Löblein, H
    Tavakoli, R
    Wilhelm, M
    Hofer, C
    Seiffert, B
    Turina, M
    Genoni, M
    BRITISH JOURNAL OF SURGERY, 2004, 91 (07) : 918 - 919
  • [10] Conversion between B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in perioperative risk assessment: protocol for a prospective cohort study
    Davidson, Taryn
    Parlow, Joel
    King, Ben
    Dumerton, Deborah
    Roshanov, Pavel S.
    Devereaux, P. J.
    Leitch, Jordan
    BMJ OPEN, 2023, 13 (05):